3 research outputs found
Both early-onset and late-onset ventilator-associated pneumonia are caused mainly by potentially multiresistant bacteria
Objective: To compare the causative pathogens of early-onset and
late-onset ventilator-associated pneumonia (VAP) diagnosed by
bronchoalveolar lavage quantitative cultures. Most previous reports have
been based on endotracheal aspirate cultures and gave uncertain
findings. Design: Prospective evaluation of consecutive patients with
clinical suspicion for VAP. Setting: Multidisciplinary intensive care
unit of a university hospital. Patients and participants: During a
3-year period 473 patients with clinical suspicion of VAP entered the
study. Diagnosis of VAP was confirmed by cultures of bronchoalveolar
lavage (>10(4) cfu/ml) specimens in 408 patients. Interventions:
Protected bronchoalveolar lavage samples were taken. Initial antibiotic
therapy was modified upon bronchoalveolar lavage culture results.
Measurements and results: Among 408 patients 191 had early-onset (<7
days mechanical ventilation) and 217 late-onset (>= 7 days) VAP.
Potentially multiresistant bacteria, mainly Pseudomonas aeruginosa and
methicillin-resistant Staphylococcus aureus (MRSA), were the most
commonly isolated pathogens in both types of VAP. No difference was
noted in the contribution of potentially multiresistant pathogens (79%
vs. 85%), P. aeruginosa (42% vs. 47%), or MRSA (33% vs. 30%)
between early-onset and late-onset VAP. Initial antibiotic therapy was
modified in 58% of early-onset VAP episodes and in 36% of late-onset
VAP episodes. No difference in mortality was found between the two types
of VAP. Conclusions: Both early-onset and late-onset VAP were mainly
caused by potentially multiresistant bacteria, most commonly P.
aeruginosa and MRSA. Antimicrobial agents against these pathogens should
be prescribed empirically, at least in our institution
Procalcitonin and procalcitonin kinetics for diagnosis and prognosis of intravascular catheter-related bloodstream infections in selected critically ill patients: a prospective observational study
<p>Abstract</p> <p>Background</p> <p>Procalcitonin (PCT) has emerged as a valuable marker of sepsis. The potential role of PCT in diagnosis and therapy monitoring of intravascular catheter-related bloodstream infections (CRBSI) in intensive care unit (ICU) is still unclear and was evaluated.</p> <p>Methods</p> <p>Forty-six patients were included in the study, provided they were free of infection upon admission and presented the first episode of suspected CRBSI during their ICU stay. Patients who had developed any other infection were excluded. PCT was measured daily during the ICU hospitalization. Primary endpoint was proven CRBSI. Therapy monitoring as according to infection control was also evaluated.</p> <p>Results</p> <p>Among the 46 patients, 26 were diagnosed with CRBSI. Median PCT on the day of infection suspicion (D0) was 7.70 and 0.10 ng/ml for patients with and without proven CRBSI, respectively (p < 0.001). The area under the curve (AUC) for PCT was 0.990 (95% CI; 0.972 – 1.000), whereas a cut-off value of 0.70 ng/ml provided sensitivity and specificity of 92.3 and 100% respectively. In contrast, the AUC for white blood cells (WBC) was 0.539 (95% CI; 0.369 – 0.709), and for C-reactive protein (CRP), 0.603 (95% CI; 0.438 – 0.768). PCT was the best predictor of proven infection. Moreover, an increase >0.20 ng/ml of PCT between the D0 and any of the 4 preceding days was associated with a positive predictive value exceeding 96%. PCT concentrations from the D2 to D6 after suspected infection tended to decrease in controlled patients, whereas remained stable in non-controlled subjects. A PCT concentration exceeding 1.5 ng/ml during D3 was associated with lack of responsiveness to therapy (p = 0.028).</p> <p>Conclusions</p> <p>We suggest that PCT could be a helpful diagnostic and prognostic marker of CRBSI in critically ill patients. Both absolute values and variations should be considered.</p